ReShape Lifesciences

About:

ReShape Lifesciences is a developer of medical devices to treat obesity and metabolic diseases.

Website: https://www.reshapelifesciences.com/

Twitter/X: ReShapeLifesci

Top Investors: National Institutes of Health, U.S. Venture Partners, Silicon Valley Bank, SV Health Investors, Venture Investors

Description:

ReShape Lifesciences is a weight-loss solutions company that offers an integrated portfolio of proven products and services that manage and treat obesity and metabolic diseases. The FDA-approved Lap-Band System provides minimally invasive, long-term treatment of obesity. It is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

Total Funding Amount:

$186M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)ReShapeLifesci.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-11-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai